Bicycle Therapeutics PLC (NASDAQ:BCYC)
| 15.92 Delayed Data As of May 27 |  +0.92 / +6.13%Today’s Change | 14.43 Today|||52-Week Range 62.08 | -73.85% Year-to-Date |
Latest BCYC News | Press Releases
No recent news for Bicycle Therapeutics PLC.
Today’s Trading
| Previous close | 15.00 |
| Today’s open | 14.69 |
| Day’s range | 14.49 - 16.13 |
| Volume | 31,155 |
| Average volume (3 months) | 474,264 |
| Market cap | $513.8M |
Data as of 4:00pm ET, 05/27/2022
Growth & Valuation
| Earnings growth (last year) | +0.71% |
| Earnings growth (this year) | -31.30% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +11.70% |
| P/E ratio | NM |
| Price/Sales | 130.43 |
| Price/Book | 1.48 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VXRTVaxart Inc | +0.32 | +9.41% |
| STOKStoke Therapeutics I... | +0.45 | +3.89% |
| ACETAdicet Bio Inc | +1.47 | +14.33% |
| ATRAAtara Biotherapeutic... | +0.35 | +7.19% |
Data as of 4:00pm ET, 05/27/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | -$0.83 |
| Annual revenue (last year) | $11.7M |
| Annual profit (last year) | -$66.8M |
| Net profit margin | -571.25% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
